Impact of Change of Head and Neck Position on Cricothyroid Membrane Localization and Membrane Height in Parturient Patients

Impact of Change of Head and Neck Position on Cricothyroid Membrane Localization and Membrane Height in Parturient Patients: an Observational Study

The cricothyroid membrane acts a route through which the upper airway can be accessed in order to provide oxygen and ventilation to patients. The need to provide oxygen and ventilation to patients is essential particularly under general anesthesia, where patients may lose the ability to breathe for themselves. Access through this membrane to provide oxygen and ventilation is critical in emergency situations where other traditional means to access the airway (e.g through endotracheal ventilation, supraglottic airway devices or face mask ventilation) have failed. It is known that due to the physiological changes of pregnancy, the upper airway of the body undergoes changes that can make accessing the airway through traditional means more difficult. Ultrasound is becoming increasingly popular due to its ability to identify the cricothyroid membrane, to improve success in accessing the airway through the cricothyroid membrane. Studies to date in non pregnant adults have shown that alterations in the head and neck position can alter the position and size of the cricothyroid membrane. No study to date however has looked at how changing the position of the head and neck effects the position and size of the cricothyroid membrane in pregnant patients. It is important to study these changes in the pregnant population, given the physiological changes of pregnancy that make accessing the airway through traditional methods more difficult in non pregnant patients. The investigators hypothesize that in pregnant patients in the third trimester, that changing the head from the neutral to maximally extended neck position will alter the position of the cricothyroid membrane in relation to anatomical skin markings between positions. The investigators also hypothesize that in pregnant patients in the third trimester that changing the head from the neutral to maximally extended neck position will increase the size of the cricothyroid membrane. The investigatorsalso aim to determine at what position in the neck a theoretical standardized incision will allow access to the cricothyroid membrane.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This is an observational study.

Participants:

  1. One of two anesthesiologists trained in cricothyroid membrane ultrasound scanning technique in pregnant population (study investigators)
  2. Subjects to be assessed: pregnant patients in their third trimester on the labor and delivery floor comfortable enough to take part in the study

Two anesthesiologists will undergo ultrasound imaging training by an expert staff anesthesiologist whom is already trained in the procedure. As per previous published evidence on this, the investigator will need to correctly identify the location of cricothyroid membrane and its height in 15 volunteers. This will constitute the standardized training component of the study.

Upon admission to the Labor and Delivery floor, women will be further explained the protocol and asked to sign the consent form. Then, they will have the cricothyroid membrane assessed, as per description above, and quantitative assessment will be performed. Firstly, quantitative assessment of the height of the cricothyroid membrane will be performed in the supine position (with left uterine displacement) with the neck in the neutral position. The central point of the cricothyroid membrane will be marked using a removable skin ink marker. The patient will then be asked to fully their neck. The change in distance of the midpoint of the cricothyroid membrane from the neutral head and neck position to fully extended positioned will be performed, as will the change in height of the cricothyroid membrane between the two positions.

Quantitative assessment for change in central cricothyroid membrane distance will be done with measuring central points marked on the patients neck with skin marker ink. Quantitative assessment of change in cricoid thyroid membrane will be conducted using caliper measuring software build into the ultrasound machinery. Finally, the investigators will establish the starting distance above the sternal notch over which a theoretical 8cm incision in the neck which will overlie the cricothyroid membrane. This will be done by measuring the distance above the sternal notch with a surgical measuring ruler.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5G1X5
        • Mount Sinai Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant patients in third trimester (>28/40 weeks)
  • Ability to understand the rationale of the study assessments and to provide signed consent.

Exclusion Criteria:

  • Neck arthritis
  • Cervical stenosis
  • Known cervical degenerative disc disease
  • Rheumatoid Arthritis
  • Any restriction of neck movement
  • Upper limb neurology
  • Patient refusal
  • Non pregnant patients
  • Pregnant patients less than 28 weeks pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ultrasound
Ultrasound measurements of the cricothyroid membrane.
Ultrasound scan of the cricothyroid membrane

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cricothyroid membrane position change
Time Frame: 30 minutes
To measure the distance the center of the cricothyroid membrane changes position on ultrasound between neutral and maximal neck extension in third trimester patients.
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cricothyroid membrane size change
Time Frame: 30 minutes
To measure the distance that the size of the cricothyroid membrane changes position on ultrasound between neutral and maximal neck extension in third trimester patients.
30 minutes
Distance above sternal notch
Time Frame: 30 minutes
The starting distance above the sternal notch in the neck over which an 8cm incision in the neck should overlie the cricothyroid membrane
30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Naveed Siddiqui, MD, Mount Sinai Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 4, 2019

Primary Completion (Actual)

December 20, 2019

Study Completion (Actual)

December 20, 2019

Study Registration Dates

First Submitted

October 22, 2019

First Submitted That Met QC Criteria

October 22, 2019

First Posted (Actual)

October 24, 2019

Study Record Updates

Last Update Posted (Actual)

September 11, 2020

Last Update Submitted That Met QC Criteria

September 10, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 19-05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Complication of Anesthesia

Clinical Trials on Ultrasound

3
Subscribe